Home
HelpTest Code LYMES Lyme Ab w/reflex (Modified 2 Tier)
Specimen Requirements
Preparation of Patient:
None
Container Type:
Gold Top SST Gel & Clot Activator Tube
Specimen Type:
Serum
Specimen Volume:
2.5 mL of Serum minimum 1.0 mL of Serum
Specimen Handling/Transport:
Separate serum from cells within 2 hours of collection.
Transport refrigerated 2-8°C.
Specimen Stability/Storage:
8 hours ambient room temperature
5 days refrigerated 2-8°C
Specimen Rejection:
Gross hemolysis
Gross Lipemia
Performing Laboratory
Munson Medical Center Laboratories
Priority, Frequency, & Turnaround
Priority:
Non-Emergent
Frequency:
Monday and Thursday
Turnaround:
0 - 5 days
Methodology
Chemiluminescent, Modified Two-Tier Testing (MTTT)
Flow Diagram
*
.
Reporting
Reference Range:
Negative
Linearity Range:
0.01 - 10 Index Units
Critical Decision:
None
Result Interpretation:
Note: All positive and/or repeated equivocal results will be tested for the presence of specific IgG and/or IgM antibodies in accordance with the modified two-tier testing (MTTT) Algorithm for Lyme Disease.
Clinical Significance
To determine exposure or immune status to Borrelia burgdorferi, the causative agent for Lymes disease
Lyme disease is caused by the tickborne spirochete Borrelia burgdorferi and is the most common vector-borne disease in the United States. The CDC initiated surveillance for Lyme disease in 1982, and since 1991 Lyme disease has been a nationally reportable disease. In the United States, the disease is primarily localized to states in the northeast, mid-Atlantic, upper north-central regions and northwestern California. The bacterium, Borrelia burgdorferi is the etiologic agent of Lyme borreliosis, a disease which is transmitted by different tick species of the genus Ixodes.
Additional Tickborne Disease testing is availible through Mayo laboratories. See testing algorithm for more information Acute_Tick-Borne_Disease_Testing_Algorithm
CPT Code
86618